2 completed. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
Follow BioArctic AB: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety, Tolerability, and Pharmacokinetics of Exidavnemab in Patients With Parkinson's Disease and Patients With Multiple System Atrophy exidavnemab, Placebo Comparator - Parkinson Disease, Multiple System Atrophy | Phase 2 | Completed | BioArctic AB | 38 | 2024-10-24 | 2026-08-21 |
| Safety and Efficacy of SC0806 (Fibroblast Growth Factor 1 and a Device) in Traumatic Spinal Cord Injury Subjects SC0806 and rehabilitation, Rehabilitation only - Spinal Cord Injury | Phase 1 / Phase 2 | Completed | BioArctic AB | 10 | 2015-06-01 | 2025-09-22 |
Multiple System Atrophy (1) · Parkinson Disease (1) · Spinal Cord Injuries (1)
Rehabilitation (1)
Poland (1) · Spain (1) · Sweden (1)
Hans Basun, MD (1)